Advanced search

Report side effect

Report a suspected side effect or falsified product to the MHRA Yellow Card scheme.
Go to {yellow_card_logo} site
{arrow_up} Back to top

Jinarc 15 mg tablets {equilateral_black_triangle}

Active Ingredient:
tolvaptan
Company:  
Otsuka Pharmaceuticals (UK) Ltd See contact details
ATC code: 
C03XA01
{info_black}
About Medicine
{medical_services}
Prescription only medicine
Healthcare Professionals (SmPC) Patient Leaflet (PIL) Risk Materials HCP Med Info
{arrow_left}
{arrow_right}

Educational Risk Minimisation Materials to help reduce the risk associated with using this medicine.

{pdf_link}

JINARC UK aRMM - Healthcare professionals (HCPs) Educational Guide

{healthcare_pro_orange} For Healthcare Professionals

Jinarc is a specialist product for which additional training is available prior to prescribing. If you wish to undertake this training, please visit https://www.jinarctraining.co.uk/ to register and complete the training. This guide has been developed for prescribers and healthcare professionals (HCPs) involved in the treatment of patients using Jinarc (tolvaptan). This document summarises important information on the potential risk of hepatic toxicity and provides guidance on how to manage this risk. In addition, it provides important information about pregnancy prevention before and during the treatment with Jinarc.

{pdf_link}

JINARC UK aRMM - Patient Alert Card

Jinarc is a specialist product for which additional training is available prior to prescribing. If you wish to undertake this training, please visit https://www.jinarctraining.co.uk/ to register and complete the training. This patient alert card should be used by patients who have been prescribed medicines containing tolvaptan and should carry with them at all times when taking this medicine. This card contains important safety information that patient needs to be aware of before, during, and after treatment with Jinarc (tolvaptan).

{pdf_link}

JINARC UK aRMM - Patient/Carer Education Brochure

Jinarc is a specialist product for which additional training is available prior to prescribing. If you wish to undertake this training, please visit https://www.jinarctraining.co.uk/ to register and complete the training. The guide should be provided to patients by the prescribing physician and includes a description of the risks of treatment, guidance on what to do in the event of risks occurring and an overview of treatment monitoring.

{pdf_link}

JINARC UK aRMM - Healthcare Professionals (HCPs) prescribing checklist

{healthcare_pro_orange} For Healthcare Professionals

Jinarc is a specialist product for which additional training is available prior to prescribing. If you wish to undertake this training, please visit https://www.jinarctraining.co.uk/ to register and complete the training. This material is provided by Otsuka Pharmaceuticals as a licence requirement for this medicine and forms part of the Risk Management Plan.

You are trying to reach document intended for healthcare professionals only.

Are you a healthcare professional?

Log in or sign up to avoid further verifications.

Otsuka Pharmaceuticals (UK) Ltd
Company image
Address
2 Windsor Dials, Arthur Road, Windsor, SL4 1RS, UK
WWW
http://www.otsuka-europe.com
Telephone
+44 (0)20 3747 5300
Fax
+44 (0)20 8848 0529
Medical Information e-mail
[email protected]